Hyun, Insoo http://orcid.org/0000-0001-6605-7112
Scharf-Deering, J. C. http://orcid.org/0000-0001-8924-3479
Sullivan, Sarah
Aach, John Dennis
Arlotta, Paola http://orcid.org/0000-0003-2184-2277
Baum, Matthew L. http://orcid.org/0000-0001-6840-8932
Church, George M. http://orcid.org/0000-0003-3535-2076
Goldenberg, Aaron
Greely, Henry T. http://orcid.org/0000-0002-1105-6734
Khoshakhlagh, Parastoo
Kohman, Richie E. http://orcid.org/0000-0002-7412-671X
Lopes, Melissa
Lowenthal, Caroline
Lu, Aric http://orcid.org/0000-0002-8276-8077
Ng, Alex H. M.
Pasca, Sergiu P. http://orcid.org/0000-0002-3216-3248
Paulsen, Bruna
Pigoni, Martina
Scott, Christopher T.
Silbersweig, David A.
Skylar-Scott, Mark A.
Truog, Robert D.
Lunshof, Jeantine E. http://orcid.org/0000-0002-5630-7947
Article History
First Online: 18 October 2022
Competing interests
: A.H.M.N. and P.K. are inventors on patents filed by the Presidents and Fellows of Harvard College and GC Therapeutics, Inc., and are co-founders of and have equity in GC Therapeutics, Inc. I.H. is a bioethics advisor for Bayer, the Novo Nordisk Foundation, and Rumi Therapeutics. P.A. is a member of the scientific advisory board at Herophilus, Rumi Therapeutics, and Foresite Labs, and is a co-founder of Vesalius. M.A.S.-S. and A.L. have submitted a patent application associated with engineered brain organoids (US Provisional Application Serial No. 63/048,502, filed July 6, 2020). Stanford University holds patents for the generation of cortical organoids/spheroids and assembloids (listing S.P.P. as an inventor). From September 1, 2021, M.P. has been an employee of Roche. G.M.C.’s competing interests are listed at ExternalRef removed. The remaining authors declare no competing interests.